Search research articles
Contact Us
Filters
Showing results (241-250 of 327) with videos related to
Page
of 33
Sort By:
Clinical Pharmacology in Drug Development
|
April 30, 2016
Pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in renal and hepatic impairment patients
Xuejun Chen, Jack G Shi, Thomas Emm, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 9, 2022
Genomic Scar Score: A robust model predicting homologous recombination deficiency based on genomic instability
Wuzhou Yuan, Jing Ni, Hao Wen, et al.
Blood
|
April 27, 2018
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
Tycel J Phillips, Andres Forero-Torres, Taimur Sher, et al.
Pediatric Blood & Cancer
|
May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)
Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
European Journal of Radiology
|
October 1, 2025
Longitudinal changes in tumor morphology and body composition following neoadjuvant chemotherapy predict progression-free survival in adenocarcinoma of the esophagogastric junction: A multi-center study
Chenglong Luo, Wanling Mu, Haojie Zhang, et al.
BMC Medical Imaging
|
April 7, 2026
Multimodal radiomics for early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer: integration of amide proton transfer weighted imaging in radiomics
Mingzhe Xu, Ailing Wang, Dongqiu Shan, et al.
European Journal of Pharmacology
|
June 21, 2021
Editing flagellin derivatives for exploration of potent radioprotective agents
Tong Shi, Jun Jiang, Meng Gao, et al.
Journal of Clinical Pharmacology
|
May 24, 2011
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers
Jack G Shi, Xuejun Chen, Thomas Emm, et al.
Plos Pathogens
|
July 20, 2021
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques
Jing Wen, Tracy Cheever, Lan Wang, et al.
Genomics
|
November 25, 2019
Construction of a high-density genetic map with whole genome sequencing in Nicotiana tabacum L
Zhijun Tong, Juhong Zhou, Zhihui Xiu, et al.
Page
of 33
Search research articles
Search
Showing results (241-250 of 327) with videos related to
Sort By:
Page
of 33
Clinical Pharmacology in Drug Development
|
April 30, 2016
Pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in renal and hepatic impairment patients
Xuejun Chen, Jack G Shi, Thomas Emm, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
December 9, 2022
Genomic Scar Score: A robust model predicting homologous recombination deficiency based on genomic instability
Wuzhou Yuan, Jing Ni, Hao Wen, et al.
Blood
|
April 27, 2018
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma
Tycel J Phillips, Andres Forero-Torres, Taimur Sher, et al.
Pediatric Blood & Cancer
|
May 16, 2015
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)
Mignon L Loh, Sarah K Tasian, Karen R Rabin, et al.
European Journal of Radiology
|
October 1, 2025
Longitudinal changes in tumor morphology and body composition following neoadjuvant chemotherapy predict progression-free survival in adenocarcinoma of the esophagogastric junction: A multi-center study
Chenglong Luo, Wanling Mu, Haojie Zhang, et al.
BMC Medical Imaging
|
April 7, 2026
Multimodal radiomics for early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer: integration of amide proton transfer weighted imaging in radiomics
Mingzhe Xu, Ailing Wang, Dongqiu Shan, et al.
European Journal of Pharmacology
|
June 21, 2021
Editing flagellin derivatives for exploration of potent radioprotective agents
Tong Shi, Jun Jiang, Meng Gao, et al.
Journal of Clinical Pharmacology
|
May 24, 2011
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers
Jack G Shi, Xuejun Chen, Thomas Emm, et al.
Plos Pathogens
|
July 20, 2021
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques
Jing Wen, Tracy Cheever, Lan Wang, et al.
Genomics
|
November 25, 2019
Construction of a high-density genetic map with whole genome sequencing in Nicotiana tabacum L
Zhijun Tong, Juhong Zhou, Zhihui Xiu, et al.
Page
of 33